1 / 2

Preeclampsia Diagnostics Market Size & Share Analysis

Preeclampsia Diagnostics Market Size & Share Analysis

Manisha109
Download Presentation

Preeclampsia Diagnostics Market Size & Share Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Preeclampsia Diagnostics Market Analysis The global preeclampsia diagnostics market is projected to grow from $1.11 billion in 2024 to $1.36 billion by 2032, with a CAGR of 2.6%. North America leads the market with a 37.61% share as of 2023. Key Market Developments Recent innovations in diagnostic technologies include:  July 2023: FDA approval of Thermo Fisher Scientific's first blood test for predicting preeclampsia in women between 23-35 weeks of pregnancy  March 2022: National Institute for Health and Care Excellence (NICE) recommended four tests including DELFIA Xpress PLGF and Elecsys immunoassay  February 2024: University College Dublin researchers initiated new preeclampsia diagnosis research using SAS technology Market Drivers The market growth is driven by: 1.Rising Disease Prevalence  Global preeclampsia incidence: 2-10% of pregnancies  Higher rates in developing countries (1.8-16.7%) vs developed nations (0.4%)  France reported 8.5% prevalence among pregnant women in 2021 2.Technological Advancements  Introduction of biomarker tests (PIGF and SFLT-1)  Development of rapid point-of-care diagnostics  Integration of AI and machine learning in detection methods Market Segmentation By Test Type  Blood Tests (dominant segment)  Urine Analysis By Product  Instruments  Consumables (largest market share) By End-user  Hospitals  Specialty Clinics  Diagnostic Centers (fastest growing segment)

  2. Others Regional Analysis 1.North America  Market value: $0.41 billion (2023)  Highest adoption of advanced diagnostic technologies  Strong healthcare infrastructure 2.Europe  Large patient pool  Increasing government approvals for diagnostic solutions 3.Asia Pacific  Fastest growing region  Driven by high pregnancy rates  Increasing adoption of fertility treatments Report- Fortune Business Insights - Preeclampsia Diagnostics Market Size & Global Report 2032 https://www.fortunebusinessinsights.com/industry-reports/preeclampsia-diagnostics-market- 101519

More Related